Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1984-08-17
1985-12-17
Roberts, Elbert L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
26023957, A61K 3158
Patent
active
045593310
ABSTRACT:
Novel 7.alpha.-substituted 3-oxo-17.alpha.-pregn-4-ene-21,17-carbolactones of the formula ##STR1## wherein ##STR2## is a CC single or CC double bond or the group ##STR3## R.sup.7 is the group SR', R' being a hydrogen atom or a straight-chain or branched alkyl residue of 1-6 carbon atoms optionally substituted by a hydroxy or acyloxy group, the group COOR" or the group COR" wherein R" is an alkyl group of 1-4 carbon atoms and ##STR4## is a CC single bond or the group ##STR5## have antialdosterone activity with reduced endocrinological side effects.
REFERENCES:
patent: 4129564 (1978-12-01), Wiechert et al.
patent: 4291029 (1981-09-01), Wiechert et al.
patent: 4450107 (1984-05-01), Nickisch et al.
patent: 4450170 (1984-05-01), Beeley et al.
patent: 4500522 (1985-02-01), Nickisch et al.
Bittler Dieter
Esperling Peter
Laurent Henry
Losert Wolfgang
Nickisch Klaus
Roberts Elbert L.
Schering Aktiengesellschaft
LandOfFree
7.alpha.-Substituted 3-oxo-17.alpha.-pregn-4-ene-21,17-carbolact does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7.alpha.-Substituted 3-oxo-17.alpha.-pregn-4-ene-21,17-carbolact, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7.alpha.-Substituted 3-oxo-17.alpha.-pregn-4-ene-21,17-carbolact will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2175110